Additionally, intravesical bacillus calmette-guerin immunotherapy increased the CD4+ T cell population more effectively than intravesical chemotherapy (43).Studies showed that viruses, especially HPV, may be a risk factor for urothelial carcinoma of the bladder (44–46). Here, CD4 is linked to bladder transitional cell carcinoma.